Jagsonpal Pharmaceuticals informs about Code of Conduct of Fair Disclosure

08 Jun 2015 Evaluate

Jagsonpal Pharmaceuticals has informed that Pursuant to Regulation 8 & 9 of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015, the Company has submitted the Code of Practices and procedures for fair disclosure of Unpublished Price Sensitive Information.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

193.75 -5.15 (-2.59%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×